血细胞外囊中含有蛋白质生物标志物,用于捕获代谢功能障碍相关的性肝病的阶段:初步探索性研究
Yakun Li1, Koen C van Son2,3,4, Sandra Serna-Salas1
1Department of Gastroenterology and Hepatology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9700 RB Groningen, The Netherlands.
Biomolecules
|November 27, 2025
概括
血细胞外囊泡 (EVs) 显示出与代谢功能障碍相关的脂肪性肝病 (MASLD) 严重程度相关的独特蛋白质特征. 这些发现表明,EVs可能作为MASLD进展的非侵入性生物标志物.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 生物标志物发现发现
- 蛋白质组学是指蛋白质组学.
背景情况:
- 与代谢功能障碍相关的脂肪性肝病 (MASLD) 的患病率正在上升,需要用于疾病评估的非侵入性生物标志物.
- 由于其分子载荷,血中的细胞外囊泡 (EV) 是可访问的生物标记物的有希望的来源.
- 目前用于MASLD的诊断方法通常需要侵入性手术,从而需要替代方法.
研究的目的:
- 为了识别与MASLD关键组织学特征相关的血衍生EV中的蛋白质签名,包括肥胖症,肥胖肝炎 (MASH) 和纤维化.
- 为了将已识别的EV蛋白质配置文件与基于非侵入性磁共振 (MR) 的肝脏成像参数相关联.
- 评估特定的EV蛋白作为MASLD活动和进展的诊断生物标记物的潜力.
主要方法:
- 从70名MASLD患者的血衍生的EVs的蛋白质基因分析.
- 对蛋白质表达差异的分析与食度 (S1与S3) 相关.
- EV蛋白与MR成像参数 (PDFF,cT1) 的相关性以及纤维化阶段的MR弹性学 (F2与F3).
主要成果:
- 在轻度 (S1) 和高级 (S3) 肥胖症之间观察到明显的EV蛋白质概况.
- 高水平的H4C1,OIT3和ANPEP,以及降低水平的CCDC25和KLHL41与晚期肥胖症有关.
- 补充成分7 (C7) 在晚期纤维化 (≥F3) 中显著上调,并显示出诊断潜力 (AUC 0.80-0.83).
- 在MASH中,GP1BA上调,但与成像参数的相关性很弱.
结论:
- 血EV含有独特的蛋白质特征,与MASLD中的肥胖症,肥胖肝炎和纤维化症的严重程度相关.
- 特定的EV蛋白,如C7,显示出其作为评估纤维化的非侵入性生物标志物的潜力.
- 这些发现支持等离子体EVs在MASLD诊断和病理生理学研究中的实用性,需要在更大的队列中进一步验证.
相关概念视频
Overview of Exosomes
3.5K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.5K
Ultrasound II: Endoscopic Ultrasound and FibroScan
512
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
512
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
170
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
170


